HYBRID EVENT: You can participate in person at Barcelona, Spain from your home or work.
4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Heart Transplantation
Heart Transplantation
It is the serious player It is a surgical procedure in which a flawed or dented heart is supplanted by a healthy and nutritious donor heart that has recently died. If a patient has a heart problem and is unable to recover from treatment, heart transplant procedures are performed.
Risk:
- Denial of the patient's heart.
- Primary graft inability
- Issue if the arteries are not removed.
- Medication side impacts
- Cancer.
Infection control by injecting medicines straight into the bone marrow, creating a pro point of entry into the institutional venous system. Once intravenous entrance is not available, this technique is used to enable fluids and medication. It is also a crucial component of the hospital's intensive care unit when there is an emergency.
Committee Members
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina Heart Congress 2026 Speakers
Syed Raza
Awali Hospital, Bahrain
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Miroslav Radenkovic
University of Belgrade, SerbiaSubmit your abstract Today
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation